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1. General introduction
Most respiratory oxidases are structurally and
functionally closely related members of a large group
of proton-pumping haem-copper oxidases which also
w xincludes mitochondrial cytochrome c oxidase 1,2 .
The cytochrome bd complex is the only well charac-
terised bacterial terminal oxidase which is unrelated
to this haem-copper oxidase superfamily. The en-
zyme functions as a quinol oxidase. Spectral evidence
as well as immunological investigations have shown
cytochrome bd to be widely distributed, particularly
w xin Gram-negative heterotrophs 3 . Spectral features
tentatively assigned to cytochrome d have also been
w xfound in a number of Bacillus species 4–9 and
 w x.some archaebacteria see 10 , although the function
of cytochrome d as terminal oxidase has not been
demonstrated in all of these organisms. Purifications
are reported from various sources, including Es-
w x w xcherichia coli 11,12 , Klebsiella pneumoniae 13 ,
w xPhotobacterium phosphoreum 14 , Azotobacter
w x w x˝inelandii 15,16 and various Bacillus species 8,9 .
This review summarises what we know about
structure and function of the cytochrome bd complex
and indicates unresolved problems which may be
belied by the apparent simplicity of the enzyme. The
E. coli and A. ˝inelandii oxidases are most exten-
sively characterised and show close similarity in their
spectral, genetic, immunological and kinetic proper-
ties. Therefore, the following paragraphs will concen-
trate on the cytochrome bd complex from these two
organisms.
2. Genetics and molecular biology
Four gene loci, cydA, cydB, cydC and cydD,
involved in the expression of the cytochrome bd
complex have been identified in E. coli. CydA and
w xcydB code for the two subunits of the oxidase 17 .
The genes are contiguous, mapping near minute 16.6
w xin the E. coli chromosome 18 . They are cotran-
scribed during cytochrome bd biosynthesis. CydA
w x w xand cydB have been cloned 19 and sequenced 20 .
A cydAB sequence was also identified in the genome
w x w xof A. ˝inelandii 21 . Sequence analysis 22 revealed
a high degree of similarlity in the derived amino acid
sequences from E. coli and A. ˝inelandii. In particu-
 186 393 19.lar, three putative haem ligands His , Met , His
and a region forming part of the proposed quinol
 .binding site are conserved Fig. 1 . In E. coli, a
further operon coding for a putative bd-type oxidase,
w xappBC, has been discovered 23 . Subsequent purifi-
cation of the AppBC protein has confirmed that the
enzyme has quinol oxidase activity, with spectral
characteristics very similar to the cydAB-encoded
w xoxidase 24 . The deduced amino acid sequence of
appBC shows about 70% similarity to the cydAB-en-
w xcoded subunits of cytochrome bd 23 , although no
cross-reaction with antibodies directed against ‘con-
ventional’ E. coli cytochrome bd has been detected
w x24 . Sequences predicted to encode bd-type oxidases
w xhave also been found in Haemophilus influenzae 25
w x  .and Bacillus subtilis 26 Fig. 1 .
CydC and cydD were also found to be contiguous
and mapped near minute 19.2–19.3 on the E. coli
w xchromosome 27,28 . Since the gene products are not
part of the functional oxidase they may be necessary
for haem biosynthesis, transport or assembly. Beb-
w xbington and Williams 29 found that cydD mutants
still produce subunit I and synthesise the haem D
containing catalase HPII. This led the authors to
conclude that cydD was not involved in regulation,
oxidase assembly or haem D synthesis, although no
data on assembly of subunit II were given. Cloning
w xand sequence analysis 30 has revealed homology
w xwith ABC membrane transporters. Poole et al. 30
propose that the function of the cydC and cydD gene
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products is the export of haem into the periplasm. It
appears that this function is not specific to haem D or
haem components of the bd complex, as defects in
cydCD also affect assembly of periplasmatic c-type
w xcytochromes in E. coli 31 . However, Goldman and
w xco-workers 32 have found that cydC mutants are
not only defective with regard to levels of periplas-
 .mic haem proteins apo- and holoprotein which can
not be corrected by addition of haemin, but also have
an altered periplasmic redox environment as judged
from the reduction level of sulphydryl groups. The
authors suggest that the cydCD transporter protein
may affect some post-secretory step in the assembly
pathway of secreted proteins and extracellular do-
mains of membrane-bound enzymes, possibly by
some function of cydCD in maintaining the periplas-
mic redox balance.
Gene clusters for oxidases commonly contain genes
coding for the protein subunits as well as genes
required for haem biosynthesis. For example, the
farnesyltransferase converting haem B into haem O
is, in E. coli, coded by the cyoE gene in the gene
w xcluster for the bo-type oxidase 33 . However, little is
known about the biosynthesis of the chlorin haem D,
w xi.e., a porphyrin with one pyrrole ring saturated 34 .
It has been shown that haem B is a precursor of haem
w xD 35 , but the reaction may not be enzyme-cata-
lysed. For catalase HPII from E. coli, cytochrome d
appears to be converted in situ from the initially
inserted b-type haem, using one of the first peroxide
w xsubstrate molecules 36 , and the protohaem in met-
myoglobin can be altered to a chlorin by in vitro
w xtreatment with hydrogen peroxide 37 . A similar
mechanism might operate in the cytochrome bd com-
plex.
It has been suggested that in E. coli and other
enteric bacteria, cytochrome bd serves as a high-af-
finity oxidase to support energy-requiring processes
under microaerobiosis and to protect anaerobic pro-
w xcesses from inhibition by oxygen 38 . In E. coli loss
of cytochrome bd leads to a lowered ability of the
organism to cope with oxidative stress, resulting in,
e.g., increased sensitivity to higher temperatures or
w xperoxide 39 . An oxygen scavenging role is also
w xexerted in respiratory protection 40,41 of the oxy-
gen-labile nitrogenase during aerotolerant nitrogen-
w xfixation in Azorhizobium caulinodans 42 or A.
w x˝inelandii 21 , an organism with the most active
respiratory chain known where cytochrome bd is
thought to be the major pathway from ubiquinol to
 w x.oxygen G70% 43 . The synthesis of cytochrome
bd is regulated by many factors, the most prevalent
being the oxygen content of the medium for a
w x.review, see 44 . Whereas in A. ˝inelandii high
aeration of the culture induces an increase in the
w xcytochrome bd level 45,46 , the second oxidase of
this organism, a poorly characterised b- or o-type
w xoxidase 47–52 , dominates under oxygen limiting
conditions. It is noteworthy that this regulation is
opposite to the E. coli system where cytochrome d is
induced during oxygen limited growth and the coex-
isting cytochrome bo complex prevails at higher
w xoxygen concentrations 53 . The modulation of cy-
tochrome bd and bo levels in response to oxygen in
E. coli has recently been linked to the Fnr and
w xArcAB regulatory proteins 54–58 , two broadly act-
ing regulators responsible, e.g., for the transition
w xbetween aerobic and anaerobic respiration 59 . Inter-
estingly, the variation of cytochrome d levels in
response to oxygen about 2–3-fold increase at oxy-
.gen limitation has been found to be much lower than
that of cytochrome bo whose expression may in-
crease up to 160-fold on transition to aerobic condi-
w xtions 54,56 . The Fnr and ArcA proteins are also
involved in transcriptional control of cytochrome bd
in response to carbon availability where they interact
with a further global regulatory protein, the catabolite
w xrepressor activator Cra 60 . In A. ˝inelandii, tran-
scription of cytochrome bd is up-regulated approxi-
mately three-fold when nitrogen-fixation is induced.
Since the cyd genes in this organism differ from the
 .genes for the nitrogen-fixing apparatus nif in not
having binding sites for a nif-specific transcription
 .  .factor nifA and s-factor ntrA , cydAB, unlike the
nif genes, is constitutively transcribed even under
non-nitrogen fixing conditions. However, the ntrA
 .protein or other ntrA-dependent gene s are required
for up-regulation of cytochrome bd during nitrogen-
w xfixation 61 . Increased expression of cytochrome bd
in A. ˝inelandii at elevated oxygen levels is also
observed in the absence of diazotrophy. CydR, a
regulatory gene upstream of cydAB, may be involved
in this control mechanism since mutations in cydR
lead to overproduction of cytochrome bd and reverse
w xresponse to oxygen 62 .
The appBC-encoded, second bd-type oxidase in
( )S. JunemannrBiochimica et Biophysica Acta 1321 1997 107–127¨110
( )S. JunemannrBiochimica et Biophysica Acta 1321 1997 107–127¨ 111
Fig. 1. Alignment of the amino acid sequences of the A. ˝inelandii, E. coli and B. subtilis cydAB, H. influenzae cyoAB and E. coli
w xappBC proteins. The amino acid sequences are as deduced from the nucleotide sequences 20,22,23,25,26 . Transmembrane-spanning
 . 19  186 393.segments TMH , His , the ligands of haem b-558 His and Met and the putative quinol domain are indicated, based on E. coli
cydAB.
E. coli also appears to be oxygen-regulated with
maximal expression under anoxic or microaerophilc
w xconditions 63 . The protein does seem to have
physiological significance since cyo cyd appB triple
mutants show increased oxygen sensitivity compared
w xto cyo cyd double mutants 23 . It has not been
investigated whether in cytochrome bd preparations
from E. coli contamination of cyd-derived oxidase
with AppBC protein does occur, leading to a possi-
ble heterogeneity problem.
3. Oxidase activity and chemiosmotic function
3.1. Enzyme kinetics
Besides the physiological substrate ubiquinol-8, in
vitro substrates of cytochrome bd include shorter-
chained ubiquinols, menadiol, duroquinol and the
w xartificial electron donors like TMPD 11,12 . Oxidase
activity depends strongly on the detergent present.
Cytochrome bd from E. coli is inactive in, e.g.,
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cholate or octylglucoside, but retains activity in
w xTween 20 and Triton X-100 64 . The ubiquinol-1
oxidase activity of cytochrome bd does not have a
clear pH maximum, but rises from pH 5.5 to reach a
w xplateau around pHG7.5 64 .
Activities with the different substrates vary widely,
in the case of quinols partly because of the steric
requirements of different substituents on the quinol
w xring 65 , partly because of varying solubility and
w xpartition properties 66 . Solubility limitations may
 .also be the origin of the apparent substrate quinol
inhibition observed with a number of ubiquinol ana-
w xlogues by Sakamoto and co-workers 65 . Using
 .ubiquinol-1 plus 2 mM DTT, at pH 7.9 turnover
numbers of around 500–1000 O Psy1 have been2
observed with the E. coli and A. ˝inelandii oxidases
w x67 . In contrast, duroquinol is a poor substrate, with
a turnover of around 50–100 O Psy1 at 1mM duro-2
quinol and a K value above 1 mM for A. ˝inelandiim
.enzyme, Junemann and Rich, unpublished data , at¨
least one order of magnitude higher than the value for
 .ubiquinol-1 see below . Similarly, the turnover with
 .TMPD plus ascorbate is comparatively low; the
V reaches around 10–30% of that with ubiquinol-1max
 .plus DTT , with a K value in the mM regionm
w x11,12 , Junemann and Wrigglesworth, unpublished¨
.data .
Several groups have measured the operational oxy-
gen affinity of cytochrome bd with considerable
variation of the resulting K values, both be-mO2.
tween different species and for oxidase from the
 w x .same organism see 67 and references therein .
However, the data led to the thought that the apparent
oxygen affinity of cytochrome bd from A. ˝inelandii,
as indicated by its K is much lower up to 3mO2.
.orders of magnitude compared to the E. coli en-
zyme. Most of these measurements were ‘one-point’
experiments at one particular concentration of reduc-
ing substrate. However, the oxidase catalyses a
multi-substrate reaction where the observed K ismO2.
modulated by the electron flow through the enzyme.
The observed K at any particular level ofmO2.
turnover will therefore depend firstly on the concen-
tration of the second substrate, ubiquinol, and sec-
ondly on the K of the enzyme for ubiquinol. Takingm
this into account, a comparative study of the E. coli
and A. ˝inelandii enzymes showed that the limiting
K values, i.e., extrapolated to saturatingmO2.
 .ubiquinol concentrations or maximum turnover , are
similar for both oxidases, 2 mM and 4 mM, respec-
tively at pH 7.9 with ubiquinol-1 plus DTT as
w x.electron donor, 67 , in good agreement with a previ-
w xous report 15 . A larger difference was observed in
the K for ubiquinol-1 at 42 mM and 220 mM,m
respectively. The K for ubiquinol is sensitive tom
detergents and lipids, giving rise to variations of up
to one order of magnitude between different experi-
w xmental conditions 11,12,15,64,67 . Although the lim-
iting K values for ubiquinol and oxygen are usefulm
parameters to compare the bd-type oxidases from
various sources, they may not be the values observed
under physiological conditions since all enzyme ki-
netic parameters, turnover and K for both sub-m
strates, are modulated by the concentrations of both
substrates. Such a process would contribute to the
regulation of overall oxygen consumption rates as
well as flux control between the alternative oxidases
in branched respiratory chains.
Kinetic measurements with purified and mem-
brane-bound cytochrome bd from E. coli and A.
˝inelandii using malate, NADH with membranes
.only or ubiquinol-1 plus DTT as electron donors did
 . w xnot show any substrate oxygen inhibition 67 , con-
w xtrary to reports by Poole and co-workers 68,69 .
3.2. Chemiosmotic function
Ubiquinol oxidase activity of the purified cy-
tochrome bd complex from E. coli is accompanied
by generation of a transmembrane potential of about
180 mV, negative inside, when reconsituted into
w x q yproteoliposomes 12,70 . A stoichiometry of 1 H re
w x71,72 can be accounted for by transmembrane
movement of electrons combined with formation of a
proton gradient by substrate protons, i.e., the release
of two protons per quinol molecule oxidised on the
periplasmatic side, and uptake of four protons per O2
molecule reduced on the cytoplasmic side of the
membrane, without invoking a proton pump.
Recently, Skulachev’s group discovered a Naq-
w xmotive terminal oxidase in E. coli 73 which, in
further experiments with mutant strains lacking either
cytochrome d or cytochrome o, has been correlated
w xwith the bd complex 74 . Consistent with this hy-
pothesis both sodium-motive respiration and cy-
tochrome d can be induced in E. coli under condi-
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tions of high Naq, low Dm , e.g., in the presence ofHq
protonophorous uncouplers or at alkaline pH, or low
 .mM concentrations of cyanide which inhibit cy-
w xtochrome bo but not bd 74–76 . However, in Bacil-
lus FTU, Naq-motive respiration does not appear to
w xbe related to cytochrome d 6 . It is difficult to see
how a mechanism based on substrate protons can be
involved for Naq-motive systems, and the role of
cytochrome bd as sodium-motive oxidase is still
controversial.
3.3. Inhibitors
A number of inhibitors has been reported for the
bd-type oxidase. These fall into two classes, haem
ligands such as cyanide acting at the oxygen binding
site and compounds known to be quinol antagonists
in other systems. Molecules binding to the oxygen
reaction site tend to be comparatively weak in-
hibitors. Most notably, several authors have pointed
out the relatively high resistance of cytochrome bd to
cyanide, with estimations of the K value in thei
1 2 w x10 –10 mM region 43,77,78 — the corresponding
value for bovine cytochrome oxidase is 50–100 nM
w x79,80 . Low sensitivity with mM amounts necessary
w xfor inhibition is also observed with nitrite 81 and
w xazide 11,12,82 . This low inhibitory potency of an-
ionic haem ligands may reflect a hydrophobic envi-
ronment at the oxygen binding site. However, in the
case of ligands to ferric haem d such as cyanide and
azide K values may be overestimated since only ai
small fraction of the enzyme population can react
 .with the inhibitor see below . Although carbon
monoxide does bind to ferrous haem d with high
affinity, as discussed below, a substantial residual
 .activity )20% is still observed at 0.5–1 mM CO
w x43,82 . This may reflect the use of haem b-595 as an
w xalternative oxygen binding site 69,83,84 , but is
probably due to a comparatively high rate constant
w x .for haem d-CO dissociation 85 , also see Table 3 .
Most of the Q-site inhibitors of cytochrome bd
have inhibitor constants in the 101–102 mM range,
e.g., HQNO, antimycin A, UHDBT, piericidin A
w x86,87 . However, the quinolone-type compounds au-
rachin C and D and their alkyl-substituted derivatives
were found to be extremely potent, close to stoichio-
w xmetric inhibitors of the oxidase 87,88 . Aurachin D
and its derivatives are of particular interest since, in
E. coli, these compounds, unlike the aurachins C, are
specific for cytochrome bd and do not inhibit cy-
tochrome bo.
The Q-site antogonists have not been systemati-
cally screened for their effect on the TMPD oxidase
activity. However, those tested antimycin A, HQNO,
.UHDBT, decyl-aurachin D did not inhibit TMPD
w xoxidation 86,88 .
4. Subunit composition and redox centres
The purified cytochrome bd complex from E. coli
contains two subunits with molecular weights of 58
 .  .kDa subunit I and 43 kDa subunit II as deter-
w xmined by SDS-gel electrophoresis 11 , consistent
with the values of 48 and 36 kDa calculated from the
amino acid sequence as deduced from the DNA
w xsequence 20 . Similar properties have been reported
for the purified A. ˝inelandii oxidase 52 kDa and 36
w xkDa, calculated from Fig. 1 in 15 ; 50 kDa and 31
w xkDa 16 ; 50.1 kDa and 35 kDa, calculated from
w x.sequence data in 22 ,the appBC-encoded enzyme
 w x.from E. coli 43 kDa and 27 kDa 24 and prepara-
tions of cytochrome bd from Klebsiella pneumoniae
 w x.52 kDa and 35 kDa 13 , Photobacterium phospho-
 w x.reum 54 kDa and 41 kDa 14 , B. stearother-
 w x.mophilus 52 kDa and 40 kDa 8 and B. firmus
 w x. OF4 35.3 kDa and 23.5 kDa 9 . It should be noted
w xthat the values of 57.4 and 42.5 kDa for E.coli 20
w xand of 59.7 and 42 kDa for A. ˝inelandii 22 quoted
in the literature for the calculation from sequence
data are higher because no allowance for water re-
.moval on peptide bond formation was made. Anti-
bodies raised against the subunits of the E. coli
complex have been used to show that proteins related
to both subunits can be found in Gram-negative
organisms where cytochrome d is detected optically
w x3 . Cross-reactivity has also been reported for Bacil-
w xlus firmus OF4 5 . In the native form the enzyme
w xprobably functions as a heterodimer 89 . Some tightly
bound lipopolysaccharide has been detected immuno-
w xlogically 90 .
Cytochrome bd contains three types of haem re-
dox centres, haem d and one molecule each of haems
b-558 and b-595, but no non-haem iron or copper
w x11,12 . Although some data have been interpreted as
being compatible with the presence of two d-type
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w xhaems per complex 91,92 , a stoichiometry of one
haem d has been established by quantitative EPR
measurements, ligand binding, determination of the
iron and haem contents and single turnover experi-
w xments 16,81,85,93–95 . Unlike cytochrome bo
w xwhich contains a tightly bound ubiquinone 96 no
quinone has been detected in purified preparations of
w xcytochrome bd from E. coli 11,12 .
The two b-type cytochromes in the complex have
distinct spectral and electrochemical properties. One
of them, b-558, is low-spin, hexacoordinate, whereas
b-595 is a high-spin, pentacoordinate haem. Spectral
analysis also indicates that haem d is directly in-
volved in oxygen binding. Construction of cydA and
cydB mutants located haem b-558 on subunit I and
demonstrated that subunit II is necessary for binding
w xof haems b-595 and d 17 . Subunit I can be ex-
pressed independently in cydB defective mutant
strains, facilitating purification of the cytochrome
w xb-558 component 97 .
5. Spectral and electrochemical properties
5.1. Optical
In the visible region, the spectrum of cytochrome
bd ‘as prepared’ is dominated by an intense ab-
sorbance peak near 650 nm due to a stable
‘oxygenated’ compound, with a shoulder at 670–680
nm arising from the oxo-ferryl form of haem d
w x95,98,99 . In the reduced form, the haem d a-peak
shifts to about 630 nm, whereas ferric haem d does
not show distinct features in the visible region. The
reduced minus oxidised spectra of the haem compo-
nents of the purified oxidase complex from E. coli
have been resolved from a set of spectra recorded at
w xdifferent redox potentials 91,100 . Cytochrome b-558
gives rise to an a-band at 560–562 nm in the abso-
lute reduced and the reduced minus oxidised differ-
ence spectra, with the b-band at 531–532 nm. A
small peak at around 595 nm is due to the a-ab-
sorbance of reduced haem b-595. In the E. coli
oxidase, the resolved spectrum of haem b-595 also
appears to exhibit a broad b-band in the 560 nm
w xregion 91,100 . The assignment of the 560nm-ab-
sorbance is important, e.g., for kinetic studies of
 w x.electron transport see 86 . Although the contribu-
tion of the haem b-595 b-band to the reduced minus
oxidised difference spectrum at 560 nm may be as
w xhigh as 50% 91,100 , it should be born in mind that
the band is broad and any changes of the sharp 560
nm peak can be assigned to haem b-558 only. The
Soret features of the three haem components have not
been resolved. However, there is some evidence from
kinetic experiments that in the ferrous form haem
b-558 absorbs near 429–430 nm and haem b-595 at
w x437–438 nm 101 . Ferrous cytochrome d is thought
to exhibit only weak features in the Soret region
w x102,103 . This idea is supported by the small ampli-
w xtude of the haem d CO binding spectrum 104,105 .
Selected peak positions and extinction coefficients
are summarised in Table 1.
Table 1
Extinction coefficients for cytochrome bd from E. coli and A. ˝inelandii
y1 y1 .  .Spectrum Organism Haem Wavelength pair nm e mM Pcm Source
w xReduced minus ‘as prepared’ E. coli d 628–649 18.8 12
 . w x628–651 27.9 pH 7.5 110
w xA. ˝inelandii 629–650 27.0 16
w xE. coli d 628–607 8.5 64
w x628–608 7.4–8.0 91
w xA. ˝inelandii 629–608 12 16
a w xE. coli b-558 561–580 21.0 110
w x560–580 14.8 12
w xE. coli b-595 595–606.5 1.9 110
w xCOrreduced minus reduced E. coli d 622–642 12.6 12
w xA. ˝inelandii 622–642 18 16
The data are for pH 7.0 unless otherwise indicated
a w xThe intensity of the 560-nm band is variable, depending on the purity of the preparation 16 . It may include spectral overlay by the
 .b-band of haem b-595 see Section 5.1 .
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Whereas cytochrome bd from K. pneumoniae and
Ph. phosphoreum and the appBC-encoded E. coli
enzyme have spectral features similar to those de-
w xscribed above 13,14,24 , the peak positions of re-
duced and ferrous CO-ligated cytochrome d are
w xshifted up to 10 nm to the blue in purified 8,9 and
w xmembrane-bound 4–6 oxidases from Bacillus
species.
5.2. EPR
In the anaerobically oxidised cytochrome d com-
plex from E. coli two major high-spin species give
w xrise to EPR signals 93,94 . One component of the
signal has rhombic features with g-values near 6.3
 .  .g and 5.5 g , the second, axial componentx y
appears at g s6.0 and g s2.0. On the basis ofx,y z
the correlation between the physicochemical proper-
ties of the EPR-detectable species and the optically
defined cytochromes, the axial signal was attributed
to cytochrome d, as were the weak rhombic signals
in the high-field region at gs1.81, 1.85, 2.3, 2.48
and 2.61. These represent low-spin sub-populations
 .of haem d together 15% of total haem d . The
rhombic signal has been assigned to haem b-595. In
 .air-oxidised ‘as prepared’ samples, a similar com-
plex high-spin signal composed of rhombic and axial
components is observed. However, under these condi-
tions, haem d is in a ferrous, oxygen-ligated form
 .see below and does not contribute to the signal.
Both rhombic and axial components in ‘as prepared’
samples have been assigned to haem b-595 on the
w xbasis of ligand binding studies 16 . The lineshape of
the composite b-595 signal shows a subtle depen-
w xdency on the ligation state of haem d 93,106,107 .
The axial form can be reversibly converted to the
rhombic form, without optical or EPR spectral effects
w xon haem d, by rising the pH 16,93 or addition of
organic solvents such as ethanol or acetone June-¨
.mann and Wrigglesworth, unpublished results .
The EPR signal of the low-spin haem b-558 is
difficult to observe. Only a weak, ramp-shaped g -z
feature at gs3.3–3.4, part of a so-called HALS
 .  w x.highly anisotropic low spin signal see 108 , has
w xbeen assigned to this redox centre 93,94,108 . The
lability of the b-558 methionine axial ligand see
.below may cause a fraction of this haem being
w xpenta-coordinate, high-spin 108 which may be the
rationale for the occasionally found assignment of the
w xaxial gs6 signal to haem b-558 109,110 .
5.3. Haem midpoint potentials
The midpoint potentials of the redox centres in
cytochrome bd from E. coli have been measured
both optically and by EPR. Values reported for cy-
tochromes b-595 and d are in good agreement, but
more variation occurs in the published E of haemm
 .b-558 Table 2 . The latter is particularly sensitive to
w xdetergents 64 . Notably, the decrease in E of haemm
b-558 induced by cholate or octylglucoside is accom-
w xpanied by some loss in quinol oxidase activity 111 .
The midpoint potential of all haems in the complex is
pH dependent between pH 6 and 10 with a D E rpHm
of y60 mV for haem d and y30 to y40 mV for
haems b-558 and b-595, indicating protonation events
w xduring reduction 64,94 .
w xIsolated cytochrome b-558 97 has very similar
properties when compared to the b-558 compound in
Table 2
Midpoint potentials at pH 7 of the cytochromes in the bd complex from E. coli
 .Sample E mV Sourcem
b-558 b-595 d
w xMembranes 165 147 260 151
w xMembranes 226 154 261 93
w xPurified bd, reconsituted in membranes 155 146 255 64
w xMembranes 195 136 260 94
w xPurified bd q50 mM octylglucoside 61 113 232 70
w xPurified subunit I — in liposomes 160 97
w xPurified subunit I — 25 mM cholate 90 97
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Table 3
Rate constants and dissociation constants of the reaction of cytochrome bd with oxygen and carbon monoxide at room temperature
Oxygen CO
y1 y1 y1 y1 y1 y1 .  .  .  .  .  .k M Ps k s K mM k M Ps k s K mMon off d on off d
d d d d d d9 7E. coli 2P10 50 0.025 8P10 1.6 0.02
a710
c b8 8A. ˝inelandii 2.8P10 10
a w x b w x c w x d w xSource: 104 ; 67 ; 105 ; 85 .
the intact bd complex, in particular, as seen from
Table 3, an unchanged value of E .m
6. Haem ligation and active site structure
Hydropathy plots of the deduced protein sequence
of the E. coli and A. ˝inelandii oxidases suggest
several transmembrane helices in each subunit, seven
w xin subunit I and eight in subunit II 20,22 , a topology
consistent with results from b-galactosidase and alka-
w xline phosphatase gene fusion experiments 112,113 ,
w xlimited proteolysis 111,114 and protein crosslinking
w xstudies 115 .
Subunit I has been implicated in the oxidation of
ubiquinol. This was initially suggested from the inhi-
bition of quinol oxidation by monoclonal antibodies
w xraised against subunit I 3 . The treatment did not
affect oxidation of TMPD. On the other hand, poly-
clonal antibodies against subunit II inhibited TMPD-
oxidation but had no influence on ubiquinol oxidase
activity. Hence, ubiquinol and TMPD bind at differ-
ent sites, possibly located on different subunits. The
epitopes of the monoclonal antibodies inhibiting
quinol oxidation were mapped to a hydrophilic loop
of 11 amino acids on the periplasmic side of the
w xbilayer 116 . This region was therefore proposed to
be part of the quinol binding domain. Limited prote-
olysis with trypsin or chymotrypsin results in selec-
tive cleaveage of subunit I at a single site close to the
proposed quinol binding domain leading to a loss in
ubiquinol oxidase activity without affecting TMPD
w xoxidation 111,114 . The location of a Q-binding site
on subunit I has been confirmed by stoichiometric
binding of the radio labeled ubiquinone-analogue
 w3 xazido-Q 3- H azido-2-methyl-5-methoxy-6-geranyl-
.1,4-benzoquinone to subunit I with subsequent loss
w xof ubiquinol oxidase activity 117 . A second molecule
of azido-Q, bound to subunit II, was ascribed to
non-specific binding. A semiquinone from bound
w xsubstrate has been described 118 .
Apart from haem b-558, the axial ligands of the
haems have not been identified at present. Only two
of the ten histidine residues, His19 and His186 on
subunit I, are essential for activity and haem ligation
w x 186119 . Whilst His has been determined as an axial
ligand of haem b-558, mutations of His19 result in
loss of both haems b-595 and d. Interestingly, this
result suggests that both subunits are involved in
binding of haems b-595 and d, since cydB mutants
 .no subunit II also lack both cytochromes b-595 and
w xd 19,97 .
The axial ligands of haems b-595 and d are not
known with certainty, and conflicting results have
been reported. In an ENDOR study by Jiang et al.
w x120 no lines in addition to those due to pyrrole
nitrogens were observed for an axial high-spin haem
 .species gs5.94 , taken to represent haem d the
authors, hence indicating the absence of a strong
nitrogenous ligand for this haem. However, the oxi-
dation state of the oxidase is not clearly defined.
Incubation of ‘as prepared’ enzyme with ferricyanide
was used to generate the fully ferric enzyme. This
method is now known to be not normally sufficient,
since interaction of ferricyanide in absence of hy-
drophobic mediators appears to be kinetically im-
w xpaired 121 . Hence, it is likely that haem b-595 in
 .one of its alternative states axial or rhombic was
observed. On the other hand, indication of a nitrogen
axial ligand to haem b-595 comes from resonance
Raman spectra on the basis of which His19 has been
w xproposed as the ligand of haem b-595 122 . The
coordination of haem d is even less clear. A nitrogen
axial ligand has also been proposed for haem d on
the basis of hyperfine splitting of the EPR signal of
w x 19ferrous, NO-ligated haem d 123 . If His is indeed
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the ligand to haem b-595, then no histidines are left
for haem d since the others appear to be non-essen-
tial by mutagenesis. Recent resonance Raman spectra
of the haem d-cyanide adduct and the oxygenated
and oxo-ferryl forms of haem d in ‘as prepared’
oxidase have been interpreted as showing the absence
of any strongly coordinated amino-acid axial ligand
w xfor haem d 122,124 . The authors suggest that haem
d has either no endogenous protein ligand or a weakly
coordinated one that is easily displaced by exogenous
ligands.
The finding that exogenous ligands such as CO
can migrate between haems b-595 and d implies that
these prostethic groups share a common binding
w xpocket 83,125 . The narrow Dn of the IR ab-1r2
sorbance bands of the haem-CO adducts indicates a
hydrophobic environment in the haem binding pocket
w x125 .
Mutagenesis of the methionine residues in cy-
tochrome bd has identified Met393 as the second
w xaxial ligand of haem b-558 126 . This would imply
close proximity of the transmembrane helices IV
 186.  393.His and VI Met . His-Met ligation of this
haem has also been suggested from recent MCD and
w xEPR studies 108 .
Ligation of b-558 by His186 places this haem close
to the putative quinol binding domain. Haem b-558
has previously been implicated in quinol oxidation. In
mutant strains containing only subunit I, but lacking
subunit II, reduction of haem b-558 by ubiquinol was
observed although the protein did not show oxidase
w x 186activity 97 . Interestingly, the His mutant does not
w xoxidise TMPD 119 . This indicates that even though
TMPD binds at a different site from ubiquinol prob-
.ably on subunit II or the subunit interface , electron
transfer from this substrate still involves haem b-558.
EPR studies on oriented multilayer preparations of
cytoplasmic membrane fragments of E. coli have
revealed that haems b-558 and d are perpendicular to
the membrane plane while haem b-595 is oriented at
an angle of approximately 558 to the membrane plane
w x127 . From these data it can be proposed that haems
b-558 and d, but not b-595, are bound between two
transmembrane helices. Haem b-595, on the other
hand, may be located outside the bilayer.
A model of the complex based on the above data is
shown in Fig. 2. This model places the haems in two
distinct active sites on opposite sides of the bilayer,
w xFig. 2. Functional model of cytochrome bd. Based on 111 . The
orientation of haems within the bilayer is drawn according to
w x127 .
b-558 facing out towards the periplasm, the other
haems binding near the cytoplasmic side of the bi-
layer. The topology of the oxidase as well as the
proposed Q-site and haem ligands are also indicated
in the sequence alignment in Fig. 1.
( )7. Reaction with ligands other than oxygen
Both pentacoordinate haems, d and to some extent
b-595, bind small exogenous ligands, such as CO,
cyanide or various nitrogen oxo-anions. Fully re-
duced oxidase has been used for most ligand binding
studies, with only limited data on interaction of lig-
ands with ferric haem d, largely because oxidised
haem d does not show distinct features in the visible
region of the spectrum. Mixed-valence compounds
have been generated from ‘as prepared’ sair-
.oxidised enzyme. The interpretation of these latter
data may be problematic due to the heterogeneity of
the starting material with regard to redoxroxygena-
 .tion state see below .
7.1. Cyanide
Incubation of ‘as isolated’ cytochrome bd with
cyanide results in decay of the oxygenated form.
Since the cyanide-induced disappearance of the 650
nm peak is faster in the presence of respiratory
substrate, it has been concluded that cyanide interacts
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with a spectrally invisible ferric form of haem d
w x78,128 . The cyanide adduct itself has no prominent
spectral features, but it does give rise to a low-spin
w xEPR-signal at gs2.96–2.99 16,93,106 . Cyanide-
induced changes to the EPR-spectrum of A. ˝inelandii
oxidase also include some loss in intensity of the
high-spin signal and, after prolonged incubation, a
w xsecond weak low-spin signal at gs3.23 16,106
which have been taken to indicate some interaction of
cyanide with haem b-595.
w xKrasnoselskaya et al. 129 note that the cyanide-
induced decomposition of the cytochrome d oxy-
compound, as monitored at 650 nm, can be kineti-
cally correlated to a redshift in the Soret region. The
authors interpret the redshift as a high-spin“ low-
spin transition of haem b-595 on cyanide binding and
propose concerted binding of cyanide to ferric haems
b-595 and d, possibly as a bridging ligand. This
would conflict with the FTIR-evidence which points
to a distance between a haem-bound CO molecule
and the adjacent second haem iron greater than the
w xVan der Waals contact distance 125 . The spectral
changes of haem b-595 on cyanide binding to ‘as
prepared’ cytochrome bd can also be interpreted as
reduction of this haem during the transition of b-
3q 2q .  2q 3q y.595 d -O to b-595 d -CN , consistent2
with resonance Raman spectra of the cyanide adduct
w x 124 and the loss in EPR intensity around gs6 see
.above .
w xTsubaki et al. 110 also propose a cyanide bridge
based on the position of the infrared band of the
cyanide adduct and the complex behaviour of the
EPR spectrum, including a novel gs3.15 signal.
However, the unusual IR frequency may be due to
the chlorin structure of haem d or to its proposed
pentacoordinate state in presence of an exogenous
w x w xligand 124 . Tsubaki et al. 110 do not account for
the electron released from haem d upon cyanide
binding to ‘as prepared’ enzyme.
Cyanide inhibits reduction of haem d, but not of
w xthe b-type haems, by quinol or dithionite 16,130 .
This is consistent with the finding that, in purified A.
 .˝inelandii oxidase, cyanide 10 mM lowers the mid-
point potential of haem d from around 240 mV to
less than y150 mV but does not affect the E valuem
of haem b-595 Junemann and Rich, unpublished¨
.data . The latter observation also indicates that
cyanide can not be a strong ligand of haem b-595.
The conclusion that cyanide does not bind to haem
b-595 has also been reached from resonance Raman
w xspectroscopy 124 .
Cyanide binding to ferrous haem d has been found
w xto be negligible 130 .
7.2. Carbon monoxide
CO binding to fully reduced cytochrome bd in-
duces a shift of the haem d a-peak from 630 nm to
636 nm. This is reflected, in the CO difference
spectrum, by a trough near 623 nm and a peak near
644 nm. In the Soret region, CO binding to haem d
gives rise to troughs at 443 nm and 415–426 nm,
with similar amplitude as the a-band signal
w x16,104,105 . The feature at 443 nm has previously
been tentatively assigned to the CO compound of
haem b-595, primarily on the grounds that haem d is
thought to contribute little to the Soret absorbance
w x102,103 , but is now, on the basis of CO recombina-
tion studies, recognised to be due to the CO adduct of
w xhaem d 104,105 . CO binding to haem b-595 how-
ever has been clearly demonstrated by FTIR at low
w xtemperatures 125 and by CO recombination after
w xflash photolysis at cryogenic 131 and room tempera-
w xture 104,105 , although the interaction occurs with
w xlow affinity 16 and is not strong enough to increase
w xthe midpoint potential of haem b-595 93 .
Some purified preparations of cytochrome bd show
a trough at 560 nm in the CO difference spectrum
w x91,104 , suggesting that some CO binding to haem
b-558 may also take place, possibly due to denatura-
tionrlability of the methionine axial ligand during
the isolation procedure.
 w x. At least three in E. coli oxidase, 104 or four in
w x.A. ˝inelandii enzyme, 105 phases of CO recom-
bination to dithionite-reduced cytochrome bd have
been resolved at room temperature. Only one of these
is due to the haem d-CO compound and the remain-
ing, slower, phases have been ascribed to reaction of
CO with the b-type haems. The rate constant of CO
binding to haem d is in the region of 107 My1 Psy1
8 y1 y1  .to 10 M Ps see Table 3 , thus approaching the
limit for a diffusion controlled reaction. Whilst CO-
trapping by haem b-595 has been demonstrated at 4K
w x125 , no indication of intermediate CO binding to
this haem following photolysis from haem d has
been observed at room temperature.
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In A. ˝inelandii, CO has been shown to displace
oxygen from haem d in ‘as prepared’ oxidase, result-
ing in a mixed-valence CO compound where both
 3q 3qb-type haems remain oxidised b-558 b-595 d
2q . w x
-CO 82,88 . The haem d a-band is also posi-
tioned at 636 nm. The broader bandwidth compared
to the fully ferrous CO compound and the partial
shift of the 650 nm peak of oxygenated haem d to
w x639 nm observed by Kauffman et al. 82 can be
attributed to an incomplete conversion of the oxy- to
the CO species. The photolysis spectrum of the haem
d CO compound in mixed-valence oxidase is identi-
w xcal to that in the fully reduced enzyme 88 , although
the recombination rate constant is 40% lower than in
w xfully ferrous enzyme 88 , possibly due to some
electron backflow following photolysis.
Under turnover conditions, haem d does also form
w xa CO adduct with an a-band at 639 nm 82 . Since
the oxo-ferryl compound absorbing at 680 nm is still
present, the spectrum is likely to represent a steady-
state mixture of the CO compound and oxygen inter-
mediates, suggesting that a high rate of CO dissocia-
tion two orders of magnitude higher than in bovine
w xheart cytochrome c oxidase, see 85 and references
.therein allows turnover to proceed in a small propor-
tion of unligated enzyme rather than via haem b-595
as an alternative oxygen binding site.
7.3. Nitrogen-containing ligands
Interaction of the ferrous enzyme with nitrogen
containing ligands has been investigated in mem-
w xbrane-bound cytochrome bd from A. ˝inelandii 82
w xand E. coli 81,92 and, more recently, in purified
w x yoxidase from both organisms 16,123,132 . NO, NO ,2
N O2y and NH OH induce a shift of the a-peak of2 3 2
reduced haem d in membrane preparations to 642
nm. The common peak position has been interpreted
as all ligands giving the same or a very similar
w xhaem-nitrosyl compound 82 . Similarly, identical
EPR spectra of a haem d–nitrosyl compound have
been obtained when dithionite-reduced oxidase was
w xincubated with NO, nitrite 123 , nitroxyl or trioxo-
dinitrate Junemann, Khan and Hughes, unpublished¨
.data . In the case of trioxodinitrate the reacting species
is thought to be the nitroxyl ion which is produced
 2yduring self-decomposition of trioxodinitrate N O2 3
y y. w x“NO qNO . Rothery et al. 81 kinetically re-2
solved two nitrite-binding haems within the oxidase
 .complex, namely haem d identified from its a-peak
and a slower species giving rise to a trough at 438
nm in the nitrite difference spectrum. The latter was
attributed to haem b-595, on the grounds that parallel
but very weak spectral changes were observed around
600 nm. This supports the previous assignment of the
shoulder on the red side of the Soret peak in the
reduced minus air-oxidised spectrum to haem b-595
 w x.see 133 . Although an earlier report has described
biphasic kinetics of NOy or NOy binding to haem d2
w x92 , quantitative EPR as well as kinetic experiments
show that a single haem d is involved in binding of
w xnitrosyl ligands 16,81 , Junemann, Khan and¨
.Hughes, unpublished data , consistent with the haem
stoichiometry.
The nitrosyl-haem EPR signal around gs2 is
composed of two distinct species, indicating two
different NO binding sites, haem d and haem b-595
w x16,123 . Both signals, that of haem d-NO at stoi-
chiometric amounts of nitric oxide and that of nitro-
syl–haem b-595 at excess NO, quantitate to one
spinrsite each per complex, indicating the absence of
spin coupling. The signal of the haem d-NO com-
pound has been shown to have a hyperfine structure
w xindicative of a nitrogen axial haem ligand 123 .
As judged from a shift of the haem d a-peak to
642–644 nm, NH OH, NO and NOy replace O in2 2 2
‘as prepared’ enzyme, leading to mixed-valence ni-
w xtrosyl compounds 82 . In this case, the NO-adduct,
but not the nitrite compound, shows a gs2 EPR
w xsignal 132 . The lineshape of this signal is more
w xaxial than in fully reduced oxidase 123,132 . NO-bi-
nding to haem d in the mixed-valence enzyme also
involves subtle lineshape changes of the haem b-595
high-spin EPR signal.
Under turnover conditions, hydroxylamine induces
a partial blueshift of the haem d a-peak, with an
w xincrease in bandwidth 82 which can be interpreted
as showing a mixture of nitrosyl and oxygenated
 .turning over haem d, similar to the findings using
CO.
Azide shows no effect on the air-oxidised enzyme
w xunless respiratory substrate is present 82 . Then, the
haem d a-band is shifted to 655 nm, accompanied by
partial inhibition of turnover. On anaerobiosis, the
a-peak of reduced cytochrome d appears at its nor-
mal position at 630 nm, suggesting that azide reacts
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with ferric but not ferrous cytochrome d and that
azide binding to haem d is not strong enough to
prevent its reduction. Azide binding to ferric haem d
has also been implied by the loss of the low-spin
w xEPR signals in the gs2.3–2.6 region 134 .
7.4. Hydroxide
 .Exposure of cytochrome bd to hydroxide pH 9
results in a reversible decay of the oxygenated form
of haem d, as judged from a loss of the a-peak near
w x 650 nm 16 . A redshift in the Soret region trough at
416 nm and peak at 432 nm in the pH9 minus pH7
.difference spectrum and signals at 560 nm and
around 590–600 nm are also observed Junemann¨
.and Wrigglesworth, unpublished results . These find-
ings can be interpreted as hydroxide-induced genera-
tion of ferric haem d, accompanied by internal elec-
tron redistribution leading to partial reduction of both
b-type haems. There is no EPR or optical evidence,
though, for the formation of a haem d-hydroxide
adduct. However, exposure to alkaline pH does in-
duce a major effect on the b-595 high-spin EPR
signal around gs6, namely a reversible lineshape
change from predominantly axial to predominantly
rhombic which is not kinetically correlated to the
decay of the haem d oxy-form, and some loss in
w xsignal intensity 16 . The latter is compatible with
partial reduction of haem b-595. The decay of the
oxygenated haem d compound under alkaline condi-
tions may be due to disruption of a hydrogen bond to
a distal amino acid residue stabilising the haem-
oxygen adduct. Exposure to OHy would leave the
complex essentially in the unligated mixed-valence
form where electron redistribution occurs due to pH-
induced shifts of the haem redox potentials. How-
ever, OHy does not appear to act as haem ligand, and
the interpretation of the observed pH-effects is still
an area of uncertainty.
7.5. O˝er˝iew
Overall, cytochrome bd contains one high-affinity
site for exogenous ligands, i.e., haem d, with haem
b-595 providing a second, low-affinity andror kineti-
cally slower site. Under non-turnover conditions, the
contribution of haem b-595 to ligand binding appears
to be minor as judged from, e.g., the lack of an Em
effect with CO or CNy, or the non-saturating CO
binding at F1mM CO. Stoichiometric binding is
only observed with excess levels of a highly reactive
ligand, NO. It is not known whether transient ligand
binding is an obligatory step during catalysis see
.below . Although haem b-558 is hexacoordinate and
would not normally have a ligand binding role, some
effects have been ascribed to this haem by Borisov
w x135 on the basis of MCD. However, the spectral
features of the low-affinityrslow ligand binding site,
in particular for CO or NO, clearly point to haem
b-595 as providing this site. Ligand binding by haem
 w x.b-558 e.g., as observed in 91 appears to be solely
due to a partially denatured oxidase preparation.
8. Reaction with oxygen and electron transfer
pathway
8.1. Oxygen-intermediates
Two stable oxy-forms of cytochrome d have been
 IIidentified, an oxygenated Fe -O , absorbing near2
.  IV650 nm and an oxoferryl Fe sO, absorbing near
. w x680 nm species 95,98,99 . Membrane and purified
preparations can be seen to be a mixture of these two
forms, with at least 70% oxygenated enzyme
w x16,129,136 , plus some fully ferric enzyme, which
may appear only as a freezing or purification artefact
w x94 .
The d2q-O species is similar to oxymyoglobin, as2
w xdemonstrated by resonance Raman spectroscopy 99 .
The oxygenated compound is formed by reversible
binding of oxygen to the one-electron reduced en-
w xzyme 136 . It has been proposed that the oxygenated
 3q 3q 2q .species b-558 b-595 d -O is not an inter-2
 .mediate in the main catalytic cycle see below .
The intermediate absorbing at around 680 nm has
previously been interpreted as a peroxy-compound of
II 2y w xthe type Fe -O 136,137 , since it can be obtained2
by reaction of excess H O with haem d in ‘as2 2
 3q 3q 2q .prepared’ enzyme b b d -O . However, reso-2
nance Raman spectroscopy indicates that scission of
the oxygen–oxygen bond has already taken place,
and the species has been identified as an oxo-ferryl
w xform 95 . A spectrally identical compound is formed
on reaction of ferric enzyme with H O , invoking a2 2
one-electron reduction by either H O or an endoge-2 2
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w xnous donor 138,139 . This reaction is reversible by
addition of catalase, however at a rate by an order of
magnitude slower compared to the expected value
 .k for peroxide calculated from the K 30 mMoff d
 y1 y1.and the k 600 M Ps and assuming a peroxy,on
w xnot an oxo-ferryl species 138,139 . This release of
the oxygen molecule from an oxo-ferryl compound
may be analogous to the oxygen exchange with bulk
water observed in compound II of various peroxi-
w xdases 140–142 .
H O -binding experiments with ‘as prepared’ oxi-2 2
dase were interpreted as showing the formation of
two distinct species, named the ‘peroxy-intermediate’
at substoichiometric amounts of peroxide and the
w x‘peroxide-state’ at excess H O 136 . However, in-2 2
teraction of peroxide with fully ferric cytochrome bd
appears to generate only one species, with the spec-
tral signature of the so-called ‘peroxy-intermediate’
w x138,139 . Only the formation of the ‘peroxide state’
from ‘as prepared’ enzyme is accompanied by decay
of the 650 nm-band of oxygenated haem d. Hence,
w xthe biphasic reaction 136 is likely to represent reac-
tion of H O with ferric and oxygenated enzyme in a2 2
preparation heterogeneous with respect to redox state
 .and oxygen ligation of haem d see above .
8.2. Electron transfer
Direct measurements of internal electron transfer
have been carried out using the flowrflash technique
w x143 and its low-temperture equivalent, followed
optically and by EPR. There are generally no quanti-
tative data from the low-temperature experiments, but
qualitatively similar results are obtained as at room
temperature. The kinetics of the two distinct b-type
haems have not been resolved.
Reaction of fully ferrous cytochrome bd with oxy-
 2q 2q 2qgen results in an oxy-adduct b-558 b-595 d -
.O , absorbing at 650 nm as a first product which2
w xdecays to give rise to the 680 nm compound 85,98 .
The transition from the oxygen-bound to the oxo-fer-
ryl form occurs at 104 sy1 at room temperature in the
w xE. coli enzyme 85 . This is kinetically correlated to
b-haem reduction, monitored at 560 nm, a spectral
region dominated by haem b-558.
Low-temperature studies of aerobic oxidation of
cytochrome bd suggest that haem b-595 may be
oxidised before haem b-558 since a Soret absorbance
at 437 nm and a feature near 590 nm are fully
developed before their counterparts at 430 nm and
w x w x562 nm 98 . EPR studies 109,144 concentrate on
the low-field region of the spectrum, i.e., showing
only the high-spin haem signals due to b-595rd, but
not the gs3.3–3.4 feature of haem b-558. How-
ever, an interesting result of these experiments is that
development of the axial and rhombic components of
the high-spin haem signal does not occur simultane-
ously, but that the rhombic species precedes the axial
 .one s . Bearing in mind that the reaction proceeds ˝ia
an EPR-silent haem d-oxy adduct to end at an equally
EPR-silent oxo-ferryl form, but not ferric d, it can be
assumed that the gs6 region is dominated by haem
b-595. Hence, the axial and rhombic signals of haem
b-595 may be associated with alternative configura-
tions of the haem pocket in different catalytic inter-
mediates.
Although electron transfer rates torfrom haem
b-595 have not been determined, a simple linear
electron transfer scheme of the order b-558“b-595
“d“O has been proposed based on low-tempera-2
w xture work 109 .
Reversed electron transfer has been measured in
decyl-aurachin D-treated, mixed-valence CO-ligated
w xoxidase from A. ˝inelandii 88 . The presence of
decyl-aurachin D leads to a shift of the b-haem
midpoint potentials resulting in an increased ampli-
tude of electron backflow following photolysis of the
CO compound. The inhibitor does not appear to
affect the rate of reversed electron transfer. Oxidation
of haem d and concomitant reduction of haem b-558
occur at a rate constant of about 3000 sy1.
8.3. Catalytic cycle
Based on the identification of some oxygen inter-
w xmediates 95,99 and the enzyme kinetics during
 .turnover with ubiquinol-1 plus DTT a catalytic
cycle, shown in Fig. 3, has been proposed for cy-
w xtochrome bd 67 . The enzyme turns over via the
one- and three- electron loaded forms, without invok-
ing a fully ferric species. Since the flow-flash experi-
 .ment ends at the oxo-ferryl enzyme 8 to 3 in Fig. 3
there is no indication of more than three reducing
w xequivalents in the fully ferrous enzyme 85 . Under
normal turnover conditions, ubiquinol binds to the
 .one-electron reduced enzyme 5 , followed by oxy-
( )S. JunemannrBiochimica et Biophysica Acta 1321 1997 107–127¨122
 .gen binding to ferrous haem d 6 . Scission of the
oxygen–oxygen bond and release of one molecule of
water lead to the formation of the oxo-ferryl form of
 .the enzyme 3 . The presence of three reducing
 .equivalents in species 1 facilitates this reaction,
leaving the enzyme in a ‘Compound II’ form as
found in the catalytic mechanism of peroxidases. The
enzyme then accepts two further electrons from
ubiquinol and, following the release of a second
molecule of water, returns to the one-electron re-
duced form. Although it can be inferred from the
relative midpoint potentials of the three haems Table
Fig. 3. Proposed catalytic cycle and reactions of ferric cytochrome bd with O and CO. Intermediates 1–7 represent the catalytic cycle2
w x  .  .proposed in 67 . The oxo-ferryl 3 and oxygenated 7 species are those found in membrane-bound and purified preparations of the
oxidase. The cycle also includes hypothetical peroxy and hydroxy intermediates. Intermediates 8“6X “1X “3 represent events during a
w x X Xflow-flash experiment 85 . The rate constants for reactions 8“6 and 6 “1 are found in Table 3. The rate constant for the formation of
 X . 4 y1 w xthe oxo-ferryl intermediate 1 “3 is k s10 s 85 .2
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.  X.2 that in the one-electron reduced form 5r5 the
electron resides mostly on haem d, an intermediate
such as 5 with ferric haem d must be populated
during the steady-state since the rate of cyanide
 .binding is enhanced during turnover see above . The
 .scheme shows the fully ferrous enzyme 6 as the
major oxygen-binding species, and the mixed-valence
 .O -compound 7 is not included in the main cycle2
but is formed at low levels or in the absence of
ubiquinol. Support for this model comes from the
observation that in oxygen-electrode assays full oxi-
dase activity is developed only after a lag phase when
the reaction is started with oxygenated enzyme
whereas no lag phase is observed with oxidase in the
w xferrous or oxo-ferryl states 145 . As yet it is not
known why the substrate binding kinetics should be
so different in the two branches as to favour step
5r5X “6 over 5r5X “7. However, binding of CO to
haem d is 40% slower in the mixed-valence form
w x88 , and it could be surmised that oxygen-binding
may follow a similar pattern. Clearly, further work is
needed to fully resolve the kinetics of the catalytic
cycle.
In E. coli the fully reduced enzyme, postulated to
be the major oxygen binding form during turnove,
has a similar K of about 20 nM for oxygen and COD
 .Table 3 . This is much lower than the operational
 .oxygen affinity K which is in the mM region. Hillm
w xet al. 85 have pointed out that this is a factor
distinguishing the bd-type oxidases from the haem-
copper oxidases. In the latter, rapid electron transfer
 .following oxygen binding lowers the K ;1 mMm
 .relative to the K ;40 mM and leads to kineticD
trapping of oxygen in an oxo-ferryl intermediate. In
contrast, cytochrome bd which shows rapid and
high-affinity O binding can be described essentially2
as a thermodynamic trap for oxygen.
9. Role of haem b-595 — a binuclear centre?
Based on the observation of CO trapping on haem
b-595 following photolysis of the haem d-CO adduct
at 4K it has been suggested that these two haems
form a binuclear centre analogous in function to the
haem-copper binuclear centre of the proton-pumping
w xoxidases 125 . However, it has since emerged that
there can not be an extensive analogy to the haem-
copper binuclear centre, and it is questionable whether
the term ‘binuclear centre’ can be applied to cy-
tochrome bd. Most importantly, no spin coupling
w xbetween haems b-595 and d has been oberved 16 .
Cyanide binding in the presence of substrate is only
w x w xthree 16 to 50-fold 78 faster than under non-
turnover conditions. This increase has been ascribed
to generation of some ferric haem d during turnover,
in contrast to mitochondrial cytochrome c oxidase
where the rates of cyanide binding to the oxidised
and the partially reduced enzyme differ by a factor of
106 due to a strong redox interaction between haem
w xa and Cu 80 . Although some redox interaction3 B
between haems b-595 and d has been noted by
w x w xMeinhardt et al. 94 , ligation of haem d to CO 93
 .or cyanide Junemann and Rich, unpublished data¨
does not alter the redox potential of haem b-595.
On the other hand, the observation of ligand mi-
w xgration 83,125 suggests that haems b-595 and d do
share a binding pocket, a fact supported by the
finding that all b-595 deficient mutants to date also
w xlack haem d 119,146 . This would be consistent with
some conformational interaction as manifested by a
subtle dependency both of the lineshape of the b-595
EPR signal around gs6 on the ligation state of
w x 2qhaem d 93,106 and of the lineshape of the d -NO
EPR signal around gs2 on the redox state of haem
w xb-595 123,132 .
At present, little is known about the function of
haem b-595 in the oxidase mechanism. Although
under non-turnover conditions ligand binding to haem
b-595 is slow and with low affinity, several lines of
evidence point to some ligand binding role of haem
b-595 during turnover. Photochemical action spectra
showing light relief of CO-inhibited samples have a
w xclear peak around 590–600 nm 43,147 . A substan-
tial residual activity is observed in presence of ap-
w xproximately 1 mM CO 43,82 . As discussed above,
this may be due to the high dissociation rate constant
of the haem d-CO adduct since at least one steady-
state oxygen intermediate, the oxo-ferryl form,can
still be clearly detected optically. However, it can
also be speculated that in the presence of CO turnover
might proceed via haem b-595 as an alternative
oxygen binding site. Oxygen binding by haem b-595
with CO-ligated haem d has been suggested by
w x w xPoole’s group 69,83 . Rothery et al. 81 have ob-
served some cooperativity during nitrite-inhibited
( )S. JunemannrBiochimica et Biophysica Acta 1321 1997 107–127¨124
oxygen consumption with an apprent number of oxy-
gen-binding sites of n)1. Although this finding
may indeed reflect oxygen binding to both haem d
and haem b-595 during turnover, it should be noted
that apparent cooperative behaviour has also been
reported for bovine heart cytochrome c oxidase where
the effect can be ascribed to changes in the ratio of
the rate constants of various electron transfer steps in
a system which does not obey simple Michaelis–
w xMenten kinetics 148,149 .
From the pH-dependency of the reaction of nitrite
w xwith haem b-595 81 and the sensitivity of its EPR
w xsignal to pH 16 it may be concluded that a protona-
tion site is close to haem b-595 which may be
involved in providing substrate protons.
If ligand binding to haem b-595 is indeed an
obligate step during catalysis, the mechanism will
still be very different from the processes at the
haem-copper binuclear centre. In the haem-copper
binuclear centre, the Cu acts as a gateway withB
oxygen binding to the copper preceding ligation to
the haem, as is reflected, e.g., in saturation kinetics of
 w x .ligand binding see 150 for a review . This contrasts
the situation in cytochrome bd where haem b-595
w xappears to have a less pronounced role 85 and may
only act as a secondary oxygen-binding site.
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